Related Experiment Video
Updated: Oct 2, 2025

13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
3.1K
SURGICAL TREATMENT FOR BREAST CANCER AND AXILLARY METASTASES: HISTORICAL PERSPECTIVE
Damir Grebić1, Aleksandra Pirjavec2, Domagoj Kustić3
1Department of General and Oncological Surgery, Clinical Hospital Center of Rijeka, Krešimirova 42, 51000 Rijeka, Croatia
Acta Medico-Historica Adriatica : AMHA
|February 25, 2022
Summary
Breast cancer treatment has evolved from radical mastectomy to breast conservation. Sentinel lymph node biopsy now often replaces axillary lymph node dissection, sparing many women unnecessary surgery.
Area of Science:
- Oncology
- Surgical Oncology
- Breast Cancer Research
Background:
- Breast cancer (BC) is the most prevalent female malignancy, with treatment evolving significantly since Ancient Egypt.
- Historical surgical approaches like radical mastectomy have been replaced by less invasive methods, improving patient quality of life.
- The development of breast conservation and sentinel lymph node biopsy (SLNB) marks major advancements in BC management.
Purpose of the Study:
- To review the historical evolution of breast cancer surgical management.
- To highlight the shift from radical mastectomy to breast-conserving surgeries.
- To discuss the impact of sentinel lymph node biopsy (SLNB) and its implications for axillary lymph node dissection (ALND).
Main Methods:
- Historical review of surgical techniques for breast cancer treatment.
- Analysis of the progression from radical mastectomy to modified mastectomies and breast conservation.
- Examination of the development and adoption of sentinel lymph node biopsy (SLNB) in axillary staging.
Main Results:
- Surgical management of breast cancer has progressed from extensive resections to minimally invasive techniques.
- Sentinel lymph node biopsy (SLNB) has become the standard for axillary staging in node-negative BC, reducing the need for axillary lymph node dissection (ALND).
- Emerging evidence suggests ALND can be omitted in select patients with 1-2 positive SLNs when combined with adjuvant radiotherapy.
Conclusions:
- Breast cancer treatment has seen a paradigm shift towards less invasive surgical options.
- SLNB has significantly improved outcomes and reduced morbidity for breast cancer patients.
- Further de-escalation of axillary treatment in breast cancer is possible with modern adjuvant therapies.

